Depression/Anxiety Flashcards
precursor to NE
tyrosine
NE synthesis steps (4)
tyrosine, L-DOPA, DA, NE
NE location in brain
locus ceruleus
5HT role
arousal, sleep-wake cycle, mood, motivaton
5HT location in brain
raphe nuclei
5HT precursor
tryptophan
which 5HT receptor is on the presynaptic terminal
1D
4 MAO-I
Phenelzine
tranylcypromine
isocarboxazid
selegiline
MOA of MAO-I
decrease MAO activity in neruons and liver
in neurons: inc. NE concentration
in liver: inc. tyramine from foods in circulation
increase NE and 5HT transmission in CNS
Antidepressants (6)
MAO-I TCA SSRI SNRI Serotonin Modulators Atypical antipsychotics
ADE for MAO-I (4)
Orthostatic hypotension
CNS stimulation
Weight gain
sexual dysfunction
TCA MOA
block uptake of amines by nerve terminals
inhibit NE and 5HT transporters
TCA drugs (5)
Amitriptyline Imipramine clomipramine protriptyline doxepin
TCA ADE
anti-ach sedation weight gain orthostatic hypotension lowered seizure threshold qt prolongation
Combine TCA and MAO-I
NO, risk of hypertensive crisis
cause tons of NE in synapse
SSRI drugs (5)
fluoxetine sertraline paroxetine citalopram escitalopram
SSRI MOA
selective inhibition of serotonin transporters
SSRI ADE
insomnia
dizziness
sexual dysfunction
GI: n/v/d
Serotonin Syndrome treatment
supportive
sedation: BDZ
cyproheptidine
Serotonin Syndrome symptoms
ataxia myoclonus confusion hypomania agitation restlessness fever chills sweating diarrhea HTN tachycardia
Withdrawal from SSRI symptoms
flu-like light-headedness restlessness sleep and sensory disturbances headache
SNRI drugs (5)
Duloxetine venlafaxine desvenlafaxine levomilnacipran milnacipran
serotonin modulators drugs (3)
trazodone
Vilazodone
Vortioxetine
Trazodone MOA
weak 5HT uptake inhibitor
5HT2A and 5HT2C antagonist
H1 antagonist: sedation
viibryd, Brintellex MOA
combined selective serotonin reuptake inhibitor and partial 5-HT1A receptor agonist
atypical antidepressants drugs (2)
Mirtazapine
Bupropion
Bupropion MOA
inhibits DA and Ne uptake
> for DA
bupropion Contraindication
history of head trauma
seizures
Mirtazapine
Antagonize alpha2 adrenergic autoreceptor
-inc. firing rate or noradrenergic neurons
-inc. NT release
antagonize 5HT2A,3 serotonin
2 theories of delayed effect of anti-depressants
- alternation in pre-synaptic auto-receptors or transports and NT synthesis
- activation of neuronal repair
stress effect on neurons
elevate glucocorticoids
increase glutamate levels
cause neuronal damage and dysfunction
reduction in BDNF (growth factor)
Antidepressants effect on CREB and BDNF
increase level of CREB (cAMP)
CREB increases BDNF
BDNF role
enhances dendritic sprouting, opposite effects of stress
Treatment of Anxiety Disorder (4)
Antidepressants
Buspirone
BZD
non-pharm
BZD MOA
selectively enhance the response to GABA to open the GABA-A receptor
what type of channel is GABA-A
chloride
GABA binding requires what 2 subunits
alpha
beta
2 subunits for BZD binding
alpha
gamma
BZD for anxiety (7)
Alprazolam Lorazepam Clonazepam Diazepam Oxazepam Chlordiazepoxide Clorazepate
BZD effect on sleep
releive symptoms of insomnia promotes onset dec. SL dec. stage 3,4, REM increase stage 2
BZD for insomnia (5)
Triazolam Estazolam Temazepam Flurazepam Quazepam
Z-hypnotics moa
bind to the bzd at alpha 1 site on the GABA-A receptor
Z-hypnotics (3)
Zaleplon
Zolpidem
Eszopiclone
alpha 1 subunit of GABA function
sedative effects of BZD
alpha 2 subunits of GABA function
anxiolytic effects of BZD
BZD antagonist
FLumazenil
Barbiturates MOA
bind to GABA-A receptor
-enhance GABA at low concentrations
-directly activate GABA at high concentration
prolong duration of channel opening
Suvorexant MOA
orexin receptor antagonist both OX1 and 2
Melatonin synthesis
in pineal gland from tryptophan